MyFinsight
Home
Blog
About
Contact
Download
Download image
Issuance of common stock
in september 2025...
$56,016K
Issuance of common stock
and warrants in...
$22,587K
Exercises of common stock
warrants
$19,737K
Issuance of common stock
in connection with...
$6,778K
Exercises of common stock
options
$280K
Proceeds from issuance of
common stock under...
$20K
Net cash provided by
financing activities
$104,961K
Canceled cashflow
$457K
Net increase in
cash, cash...
$14,076K
Canceled cashflow
$90,885K
Principal payments on
finance lease...
$457K
Change in fair value of
warrant liabilities
$40,901K
Stock-based compensation
expense
$6,684K
Prepaid expenses and
other current assets
-$2,248K
Non-cash operating lease
expense
$1,587K
Depreciation
$1,129K
Change in fair value of
notes payable,...
$424K
Accrued expenses and
other current...
$414K
Non-cash interest
expense
$296K
Inventory
-$73K
Net cash used in
operating activities
-$90,328K
Net cash used in
investing activities
-$557K
Canceled cashflow
$53,756K
Net loss
-$140,954K
Purchases of property and
equipment
$557K
Accounts payable
-$1,666K
Operating lease
liabilities
-$1,278K
Other long-term
assets and liabilities
$186K
Back
Back
Cash Flow
source: myfinsight.com
FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC. (GUTS)